2017 Immuno-Oncology Symposium

Vancheswaran Gopalakrishnan, MPH, The University of Texas MD Anderson Cancer Center, presenting Abstract #2, "Association of diversity and composition of the gut microbiome with differential responses to PD-1 based therapy in patients with metastatic melanoma"

Orlando, FL - 2017 Clinical Immuno-Oncology Symposium - Vancheswaran Gopalakrishnan, MPH, The University of Texas MD Anderson Cancer Center, presenting Abstract #2, "Association of diversity and composition of the gut microbiome with differential responses to PD-1 based therapy in patients with metastatic melanoma," during Oral Abstract Session B at the 2017 ASCO-SITC Clinical Immuno-Oncology Symposium here today, Friday, February 24, 2017. The conference, which is a collaboration between the American Society of Clinical Oncology and Society for Immunotherapy of Cancer, is focused on clinical and translational research in immuno-oncology and the implications for clinical care. Photo by © ASCO/Luke Franke 2017